Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v12-EN
Language English English
Date Updated 2024-10-31 2024-10-31
Drug Identification Number 02459981 02459981
Brand name LANCORA LANCORA
Common or Proper name Ivabradine Ivabradine
Company Name SERVIER CANADA INC SERVIER CANADA INC
Ingredients IVABRADINE IVABRADINE
Strength(s) 7.5MG 7.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 56's 56's
ATC code C01EB C01EB
ATC description OTHER CARDIAC PREPARATIONS OTHER CARDIAC PREPARATIONS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2024-10-04 2024-10-04
Actual start date
Estimated end date 2024-10-31 2024-10-31
Actual end date 2024-10-30 2024-10-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments